๐๐ข๐๐ก๐๐ง ๐๐ข๐ญ๐ข๐๐ฎ๐ฌ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐๐๐ซ๐ค๐๐ญ: ๐๐ฅ๐จ๐๐๐ฅ ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ โถ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ : https://lnkd.in/d6qaaiQg The growing prevalence of skin illnesses worldwide is fueling the expansion of the lichen nitidus treatment market, which is expected to reach a valuation of USD 282.14 million by 2031, up from USD 154.23 million in 2024. This growth is driven by advances in dermatological therapeutics and heightened awareness among healthcare professionals and patients regarding the management of this often-misunderstood skin condition. As a result, the market is projected to grow at a compound annual growth rate (CAGR) of 8.65% from 2024 to 2031. ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: โถ๐๐ฒ ๐๐ฒ๐ฉ๐: Topical, Oral. โถ๐๐ฒ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ: Corticosteroids, Retinoid, Antihistamines, Phototherapy. โถ๐๐ฒ ๐๐ง๐-๐๐ฌ๐๐ซ: Hospitals, Dermatology Clinics. โถ๐๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ฒ: North America, Europe, APAC, Latin America, and Middle East & Africa. ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐:ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย Pfizer, Novartis, Merck Sharp & Dohme Federal Credit Union, Sanofi, GSK, AstraZeneca, Hubei Gedian Humanwell Pharmaceutical Co. Ltd, Farmabios, Horizon Pharma. #LichenNitidus #SkinTreatment #Dermatology #ChronicSkinConditions #MedicalAdvancements #TreatmentOptions #SkinCareInnovation #fatposglobal
About us
- Website
-
https://wordpress.com/post/researchupdate24.wordpress.com
External link for researchupdate24
- Industry
- Market Research
- Company size
- 51-200 employees
- Type
- Privately Held
Updates
-
๐ ๐ซ๐๐๐ณ๐-๐๐ซ๐ฒ๐ข๐ง๐ /๐๐ฒ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐๐ช๐ฎ๐ข๐ฉ๐ฆ๐๐ง๐ญ: ๐๐ฅ๐จ๐๐๐ฅ ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ โถ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ : https://lnkd.in/dipC-nNN The rising demand for freeze-dried products, driven by their extended shelf life, stability, and ability to maintain quality, is propelling the growth of freeze-drying equipment usage. In the pharmaceutical and biotechnology sectors, freeze-drying is crucial for preserving sensitive biological components, vaccines, and pharmaceutical formulations, with the market projected to grow from USD 4.98 billion in 2024 to USD 8.12 billion by 2031. Advances in freeze-drying technology, including improved process control, automation, and scalability, are enhancing efficiency, reducing costs, and expanding application possibilities. Additionally, in the food industry, freeze-drying enables the production of high-quality, lightweight, and transportable food products with long shelf lives, driving the market to grow at a CAGR of 6.32% from 2024 to 2031. ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: โถ๐๐ฒ ๐๐ช๐ฎ๐ข๐ฉ๐ฆ๐๐ง๐ญ ๐๐ฒ๐ฉ๐: Bench-Top, Laboratory, Industrial, Mobile. โถ๐๐ฒ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง: Pharmaceutical, Biotechnology, Food Processing, Surgical Procedures. โถ๐๐ฒ ๐๐๐๐๐ฌ๐ฌ๐จ๐ซ๐ข๐๐ฌ: Loading & Unloading Systems, Vacuum Systems, Monitoring & Control Systems. โถ๐๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ฒ: North America, Europe, APAC, Latin America, and Middle East & Africa. ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐:ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย GEA Group, Azbil Corporation, SHANGHAI TOFFLON SCIENCE-A, IMA s.p.a., SP Industries, Inc., Cuddon Freeze Dry, Labconco Corporation, Thermo Fisher Scientific, MechaTech Systems Ltd. #FreezeDrying #Lyophilization #PharmaTech #FreezeDryingEquipment #PharmaceuticalManufacturing #FoodPreservation #CryogenicTechnology #fatposglobal
-
-
๐๐๐ฎ๐ญ๐ ๐๐ฌ๐๐ก๐๐ฆ๐ข๐ ๐๐ญ๐ซ๐จ๐ค๐ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ: ๐๐ฅ๐จ๐๐๐ฅ ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ โถ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ : https://lnkd.in/dNi8JrBJ The Acute Ischemic Stroke Drugs Market, valued at USD 9.01 billion in 2024, is projected to grow to USD 12.09 billion by 2031, with a CAGR of 4.13% from 2024 to 2031. These drugs aim to treat and mitigate the effects of an acute ischemic stroke, which occurs when a blood clot obstructs blood flow in the brain, potentially causing damage. Key treatments include thrombolytics like tissue plasminogen activator (tPA) to dissolve clots, antiplatelet drugs like aspirin to prevent new clots, and anticoagulants to manage clotting issues. Current research focuses on enhancing the efficacy and safety of existing drugs, developing novel thrombolytic agents, and optimizing dosing methods. Future advancements may involve neuroprotective drugs to minimize brain injury and therapies for brain repair, promising more effective, personalized treatments that could significantly improve patient outcomes and quality of life. ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: โถ๐๐ฒ ๐๐ซ๐ฎ๐ ๐๐ฅ๐๐ฌ๐ฌ: Tissue Plasminogen Activator (tPA), Antiplatelet Agents, Thrombolytics. โถ๐๐ฒ ๐๐จ๐ฎ๐ญ๐ ๐จ๐ ๐๐๐ฆ๐ข๐ง๐ข๐ฌ๐ญ๐ซ๐๐ญ๐ข๐จ๐ง: Oral, Intravenous (IV). โถ๐๐ฒ ๐๐ข๐ฌ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ข๐จ๐ง ๐๐ก๐๐ง๐ง๐๐ฅ: Hospital Pharmacies, Online Pharmacies. โถ๐๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ฒ: North America, Europe, APAC, Latin America, and Middle East & Africa. ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐:ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย Roche, Boehringer Ingelheim, AstraZeneca, Bristol Myers Squibb, Bayer, Eli Lilly and Company, Pfizer, Sanofi, Johnson & Johnson, and Abbott. #StrokeTreatment #AcuteIschemicStroke #StrokeDrugs #IschemicStrokeTherapies #Neuropharmacology #StrokeResearch #StrokeCare #fatposglobal
-
-
๐๐ข๐ญ๐ข๐ฅ๐ข๐ ๐จ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐๐๐ซ๐ค๐๐ญ: ๐๐ฅ๐จ๐๐๐ฅ ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ โถ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ : https://lnkd.in/dZF-StUF The market for vitiligo treatments is expanding due to increasing patient awareness and the demand for innovative therapies for this widespread skin condition. According to Verified Market Research, the vitiligo treatment market is projected to grow from USD 604.36 million in 2024 to USD 843.88 million by the end of the forecast period, driven by the need for better management solutions and advancements in treatment options. This growth is expected to continue at a CAGR of 4.7% from 2024 to 2031. ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: โถ๐๐ฒ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ: Topical, Light Therapy, Surgical Procedures. โถ๐๐ฒ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ฒ๐ฉ๐: Nonsegmental, Segmental. โถ๐๐ฒ ๐๐ง๐-๐๐ฌ๐๐ซ: Hospitals, Aesthetic Clinics. โถ๐๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ฒ: North America, Europe, APAC, Latin America, and Middle East & Africa. ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐:ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย Incyte, Astellas Pharma, Bausch Health Companies Inc., Baxter International Inc., Pfizer, Strata Skin Sciences, Dr. Reddy's Laboratories, Bristol Myers Squibb, Celgene. #VitiligoTreatment #VitiligoAwareness #SkinCondition #PigmentationDisorder #VitiligoResearch #InnovativeTreatments #DermatologyAdvances #fatposglobal
-
-
๐๐ซ๐ญ๐ข๐๐ข๐๐ข๐๐ฅ ๐๐ซ๐ ๐๐ง ๐๐ง๐ ๐๐ข๐จ๐ง๐ข๐ ๐๐ฆ๐ฉ๐ฅ๐๐ง๐ญ๐ฌ ๐๐๐ซ๐ค๐๐ญ: ๐๐ฅ๐จ๐๐๐ฅ ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ โถ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ : https://lnkd.in/d-2yAGwv The Artificial Organ and Bionic Implants Market, valued at USD 37.56 billion in 2024, is projected to reach USD 77.63 billion by 2031, growing at a CAGR of 9.5%. These medical devices replicate the functions of natural organs or body components that are damaged or missing, with artificial organs like heart valves and kidneys replacing failing organs, and bionic implants such as prosthetic limbs or bionic eyes enhancing sensory and motor functions. Advances in materials science, bioengineering, and robotics have led to the development of sophisticated solutions, including fully implantable artificial hearts and advanced prosthetics with near-natural dexterity. Emerging technologies like 3D printing, stem cell research, and nanotechnology are expected to drive further innovation, with bioprinting potentially addressing organ rejection and shortages. The integration of artificial intelligence and machine learning will enhance the adaptability and functionality of bionic devices, broadening the range of treatable conditions and improving outcomes, positioning artificial organs and bionic implants as a major focus of future medical advancements. ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: โถ๐๐ฒ ๐๐ฒ๐ฉ๐: Artificial Organs, Bionic Implants. โถ๐๐ฒ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง: Cardiovascular Implants, Orthopedic Implants, Neurological Implants. โถ๐๐ฒ ๐๐ง๐-๐๐ฌ๐๐ซ: Hospitals and Clinics, Research and Academic Institutes. โถ๐๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ฒ: North America, Europe, APAC, Latin America, and Middle East & Africa. ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐:ย ย ย ย ย ย ย ย ย Abbott, Medtronic, Johnson & Johnson, Siemens Healthineers, Stryker, Zimmer Biomet, B. Braun Group, Edwards Lifesciences, Boston Scientific, and Organovo Holdings, Inc. #ArtificialOrgans #BionicImplants #MedicalInnovation #Bioengineering #FutureOfMedicine #HealthcareTech #RoboticSurgery #fatposglobal
-
-
๐๐๐๐ ๐๐๐ฌ๐ค ๐๐๐ซ๐ค๐๐ญ: ๐๐ฅ๐จ๐๐๐ฅ ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ โถ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ : https://lnkd.in/d3X652Sr The global CPAP mask market, valued at USD 5.1 billion in 2023, is projected to reach USD 7.54 billion by 2031, with a CAGR of 6.1% from 2024 to 2031. Key drivers for this growth include the increasing prevalence of sleep apnea due to factors like obesity and aging populations, heightened awareness and improved diagnostic techniques leading to more diagnoses, and technological advancements in mask design that enhance comfort and functionality. The expansion of healthcare infrastructure in emerging markets and supportive government initiatives and insurance reimbursements are further fueling the demand for CPAP masks. ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: โถ๐๐ฒ ๐๐ง๐ ๐๐ฌ๐๐ซ: Hospitals, Home Care Settings, Sleep Clinics. โถ๐๐ฒ ๐๐ ๐ ๐๐ซ๐จ๐ฎ๐ฉ: Adults, Pediatrics. โถ๐๐ฒ ๐๐ข๐ฌ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ข๐จ๐ง ๐๐ก๐๐ง๐ง๐๐ฅ: Online Retail, Medical Supply Stores, Hospitals, Pharmacies. โถ๐๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ฒ: North America, Europe, APAC, Latin America, and Middle East & Africa. ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐:ย ย ย ย ย ย ย ย ย ResMed, Philips, Fisher & Paykel Healthcare, Sunset Healthcare Solutions, Boston Medical Center (BMC), Somnetics (Som Imaging Informatics Pvt. Ltd.), Drive DeVilbiss Healthcare, Apex Medical LLC., Medtronic, 3B Medical Center, Koala Health. #CPAPMask #SleepApnea #SleepTherapy #CPAPMachine #SleepHealth #RespiratoryCare #SleepDisorders #PublicHealthTools #fatposglobal
-
-
๐๐๐ง๐ ๐ฎ๐ ๐ ๐๐ฏ๐๐ซ ๐๐๐ฌ๐ญ ๐๐ข๐ญ ๐๐๐ซ๐ค๐๐ญ: ๐๐ฅ๐จ๐๐๐ฅ ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ โถ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ : https://lnkd.in/dRQixR3P The Dengue Fever Test Kit Market, valued at USD 642.4 million in 2023, is projected to reach USD 1,012.5 million by 2031, growing at a CAGR of 6.2% from 2024 to 2031. This growth is driven by several factors, including the rising incidence of dengue fever, particularly in tropical and subtropical regions, which increases demand for diagnostic kits. Enhanced awareness of early diagnosis and advancements in diagnostic technologies, such as rapid diagnostic tests and molecular assays, improve accuracy and speed, further fueling market expansion. Government and healthcare initiatives, including public health campaigns and international support, also contribute to increased testing needs, a growing focus on infectious disease management, rising investments in healthcare, and the emergence of new dengue virus strains drive demand for comprehensive and effective diagnostic solutions. ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: โถ๐๐ฒ ๐๐ฒ๐ฉ๐: Rapid Diagnostic Test Kits, ELISA (Enzyme-Linked Immunosorbent Assay) Kits, Molecular Diagnostic Kits, Combination Test Kits. โถ๐๐ฒ ๐๐จ๐ฆ๐ฉ๐จ๐ง๐๐ง๐ญ: Dengue NS1 Antigen Test Kits, Dengue IgM/IgG Antibody Test Kits, Dual/Combo Test Kits\. โถ๐๐ฒ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง: Hospital Diagnostics, Laboratory Diagnostics, Point-of-Care Testing. โถ๐๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ฒ: North America, Europe, APAC, Latin America, and Middle East & Africa. ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐:ย ย ย ย ย ย ย ย ย Abbott, Roche Diagnostics UK & Ireland, Bio-Rad Laboratories, Siemens Healthineers, SD BIOSENSOR INC, altona Diagnostics, Meridian Bioscience Inc., OraSure Technologies, Seegene Inc., Sysmex Corporation. #DengueFeverTest #DengueTesting #DengueAwareness #HealthcareInnovation #DiagnosticSolutions #VectorBorneDiseases #PublicHealthTools #fatposglobal
-
-
๐๐๐ง๐ญ๐๐ฅ ๐๐จ๐ง๐ ๐ ๐ข๐ฑ๐๐ญ๐ข๐จ๐ง ๐๐ข๐ญ๐ฌ ๐๐๐ซ๐ค๐๐ญ: ๐๐ฅ๐จ๐๐๐ฅ ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ โถ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ : https://lnkd.in/duSx5NmA The global Dental Bone Fixation Kits Market, valued at USD 696.8 million in 2023, is projected to reach USD 1,278.7 million by 2031, growing at a CAGR of 9.6% from 2024 to 2031. This growth is driven by several factors, including the increasing prevalence of dental disorders such as tooth loss, periodontal disease, and jawbone fractures, which heightens the demand for these kits. Technological advancements in dental procedures and materials, such as more effective and biocompatible fixation systems, enhance surgical outcomes and patient recovery, the rising geriatric population, with its associated dental issues, and the growing awareness and adoption of cosmetic dentistry procedures further boost demand. The expansion of dental clinics and hospitals, particularly in emerging markets, also contributes to the market's growth by increasing accessibility to advanced dental technologies and treatments. ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: โถ๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐๐ญ ๐๐ฒ๐ฉ๐: Screw Kits, Plate Kits, Bone Grafting Kits, Pin Kits, Resorbable Kits. โถ๐๐ฒ ๐๐๐ญ๐๐ซ๐ข๐๐ฅ: Metal Kits, Biodegradable Kits, Ceramic Kits. โถ๐๐ฒ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง: Oral Surgery, Orthodontics, Maxillofacial Surgery. โถ๐๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ฒ: North America, Europe, APAC, Latin America, and Middle East & Africa. ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐:ย ย ย ย ย ย ย ย ย Zimmer Biomet, Dentsply Sirona, Straumann Group, Danaher Corporation, Implant Direct, Nobel Biocare, Arthrex, Integra LifeSciences, Geistlich Pharma, Biora Therapeutics, axogen, Medtronic, Stryker, Johnson & Johnson, 3M, Baxter International Inc., Terumo Medical Corporation, Smith Nephew. #DentalBoneFixation #BoneFixationKits #DentalImplants #OralSurgery #DentalInnovation #BoneHealing #DentalTechnology #fatposglobal
-
-
๐๐๐๐ญ๐ข๐ง๐จ๐ฆ๐ฒ๐๐ข๐ง ๐๐๐ซ๐ค๐๐ญ: ๐๐ฅ๐จ๐๐๐ฅ ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ โถ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ : https://lnkd.in/dp8xHhPv The Dactinomycin market, valued at USD 6.9 billion in 2023 and projected to reach USD 7.81 billion by 2031 with a CAGR of 8.27% from 2024 to 2030, is driven by several key factors. Rising cancer incidences, including tumors like Wilms' and rhabdomyosarcoma, are boosting the demand for effective treatments. Advancements in cancer treatment protocols, ongoing research, and clinical trials may expand Dactinomycin's applications. The aging population and increased cancer diagnoses further elevate the need for this drug, heightened R&D investment, the availability of affordable generic versions, and improvements in healthcare infrastructure are contributing to the growing use of Dactinomycin in oncology. ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: โถ๐๐ฒ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง: Oncology, Sarcomas, Wilmsโ Tumor, Gestational Trophoblastic Neoplasia, Others. โถ๐๐ฒ ๐ ๐จ๐ซ๐ฆ: Injection, Tablets. โถ๐๐ฒ ๐๐ง๐ ๐๐ฌ๐๐ซ: Hospitals, Cancer Treatment Centers, Research Institutions. โถ๐๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ฒ: North America, Europe, APAC, Latin America, and Middle East & Africa. ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐:ย ย ย ย ย ย ย ย ย Pfizer, Teva Pharmaceuticals., Fresenius Kabi, Mylan, Hikma Pharmaceuticals, Juno Therapeutics, Inc., Accord Healthcare, Amgen. #Dactinomycin #CancerTreatment #Pharmaceuticals #Oncology #CancerResearch #DrugDevelopment #MedicalBreakthrough #fatposglobal
-
-
๐๐ซ๐๐๐ญ๐ข๐ง๐ ๐๐จ๐ง๐จ๐ก๐ฒ๐๐ซ๐๐ญ๐ ๐๐๐ซ๐ค๐๐ญ: ๐๐ฅ๐จ๐๐๐ฅ ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ โถ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ : https://lnkd.in/dkimsFNp The Creatine Monohydrate Market, valued at USD 189.2 million in 2023, is projected to grow to USD 315.2 million by 2031, with a CAGR of 11% from 2024 to 2031. Key drivers of this growth include increasing demand for sports nutrition due to heightened health and fitness awareness, the rising popularity of fitness and bodybuilding, and strong scientific research validating the effectiveness and safety of creatine monohydrate. The expansion of e-commerce has made creatine more accessible, further boosting market growth, while the overall growth of the health and wellness industry, which includes supplements for muscle building and general wellness, also supports the demand for creatine. ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: โถ๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐๐ญ ๐๐ฒ๐ฉ๐: Powder, Capsules, Liquids. โถ๐๐ฒ ๐ ๐จ๐ซ๐ฆ: Unflavored, Flavored, Other. โถ๐๐ฒ ๐๐ง๐ ๐๐ฌ๐๐ซ: Athletes and Bodybuilders, Recreational Users, General Health. โถ๐๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ฒ: North America, Europe, APAC, Latin America, and Middle East & Africa. ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐:ย ย ย ย ย ย ย ย ย Optimum Nutrition , MuscleTech, BSN SPORTS, Universal Nutrition, Dymatize, KAGED MUSCLE LTD, SSUP Holdings - Oriental Princess | Cute Press | Bisous Bisous | LALIL | GNC, Myprotein, ALLMAX Nutrition, Inc., NutraBio Labs, Inc., Vital Proteins, Evlution Nutrition. #CreatineMonohydrate #SportsSupplements #FitnessBoost #WorkoutSupplements #MuscleGrowth #PerformanceEnhancement #SupplementTrends #fatposglobal
-